Johnson Matthey PLC (LON:JMAT - Get Free Report) shares shot up 29% during mid-day trading on Thursday . The company traded as high as GBX 1,888 ($25.51) and last traded at GBX 1,792.32 ($24.22). 3,427,063 shares traded hands during trading, an increase of 25% from the average session volume of 2,743,881 shares. The stock had previously closed at GBX 1,389 ($18.77).
Johnson Matthey Stock Performance
The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The firm has a 50 day moving average price of GBX 1,319.16 and a 200 day moving average price of GBX 1,378.49. The stock has a market cap of £2.86 billion, a PE ratio of 29.06, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last released its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, research analysts forecast that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Increases Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were issued a dividend of GBX 32 ($0.43) per share. This represents a dividend yield of 1.88%. The ex-dividend date was Thursday, April 10th. This is a positive change from Johnson Matthey's previous dividend of $22.00. Johnson Matthey's dividend payout ratio is currently 130.84%.
Insider Buying and Selling
In other news, insider Liam Condon bought 30 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, April 16th. The stock was bought at an average price of GBX 1,200 ($16.22) per share, for a total transaction of £360 ($486.49). Insiders have acquired a total of 75 shares of company stock worth $99,927 in the last ninety days. 0.61% of the stock is owned by insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Stories
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
